Recombinant monoclonal antibody recognizes a unique epitope on varicella-zoster virus immediate-early 63 protein

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Varicella-zoster virus (VZV) causes significant human disease.
• The VZV immediate-early protein IE63 is crucial for viral replication.
• Existing antibodies against IE63 have limitations in specificity or application.

Purpose of the Study:

• To characterize the binding epitope of a novel recombinant monoclonal antibody (rec-MAb 63P4).
• To determine the specificity of rec-MAb 63P4 for VZV IE63.
• To differentiate the binding characteristics of rec-MAb 63P4 from existing anti-IE63 antibodies.

Main Methods:

• Construction of a recombinant monoclonal antibody (rec-MAb 63P4).
• Use of ORF63 truncation mutants to map the epitope.
• Testing antibody binding against VZV IE63 and simian IE63 counterparts.

Main Results:

• The rec-MAb 63P4 antibody specifically detects VZV IE63 in infected cell cytoplasm.
• The binding epitope was mapped to amino acids 141–150 of VZV IE63.
• This epitope is distinct from those recognized by other anti-IE63 antibodies.
• rec-MAb 63P4 does not bind to the simian IE63 protein.

Conclusions:

• rec-MAb 63P4 recognizes a unique epitope on VZV IE63.
• This antibody offers enhanced specificity for VZV IE63 detection.
• The findings contribute to developing more precise diagnostic and research tools for VZV infections.